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INTRODUCTION
The main functions of the testes are testosterone production 
and spermatogenesis. These two functions are controlled by 
the hypothalamus-pituitary-gonad axis. Gonadotropin-releas-
ing hormone (GnRH) from the hypothalamus stimulates the 
production of follicle-stimulating hormone (FSH) and lutein-
izing hormone (LH) in the anterior pituitary.1 FSH binds to its 
receptor on the surface of Sertoli cells to regulate spermato-
genesis.2,3 LH binds to its receptor on the Leydig cell mem-
brane to stimulate testosterone production. The testosterone 
produced by LH negatively regulates GnRH production in the 
hypothalamus.4-6
There are four types of forkhead box class O (Foxo) tran-
scription factors: Foxo1 (FKHR, forkhead in rhabdomyosar-
coma), Foxo3 (FKHRL2, FKHR-like1), Foxo4 (AFX, acute-lym-
phocytic-leukemia-1), and Foxo6. These Foxo proteins regulate 
stress responses, aging, insulin sensitivity, and ontogenesis,7,8 
and their transcription is inhibited by phosphoinositide 3-ki-
nase (PI3K). PI3K signaling phosphorylates AKT, which then 
phosphorylates Foxo3 at Ser24, Thr32, and Ser56 residues. These 
phosphorylated sites recruit 14-3-3 protein to guide Foxo3 from 
the nucleus into the cytoplasm. Finally, Foxo3 is removed by 
proteasomes.9 
In female reproduction, Foxo1, Foxo3, and Foxo4 are ex-
pressed in the granulosa cells at various stages of follicle de-
velopment.10 Foxo1 in granulosa cells inhibits cyclin D2 gene 
expression and increases the nuclear localization of p27kip 
proteins, which makes it a key regulator of G1/S transition. 
Foxo proteins also play an important role in regulating ovari-
an function by pituitary gonadotropins.10,11 In a previous study, 
Foxo3-null female mice exhibited age-dependent fertility is-
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sues and were completely sterile at 10 weeks or older. In Foxo3-/- 
ovaries at 9.5 weeks, oocytes in developing follicles appeared 
to have degenerated, reflecting atretic change. At 12 weeks, 
Foxo3-/- ovaries had no developing follicles. These indicated 
that Foxo3 is important in ovarian follicular development.11-13 
Meanwhile, in males, germ line specific Foxo1 KO mice showed 
defective proliferative expansion and small testes, which was 
not due to cell death, but rather to renewal of spermatogonial 
stem cells.14 However, the function of Foxo3 in Leydig cells is 
not clear.15
Foxo3 is important not only in females, but also in males. 
Foxo3 expression and location are likely to be dynamic th-
roughout life. In this study, Foxo3 expression and location 
were investigated from mouse embryonic stage to 12 weeks, 
and the role of Foxo3 in Leydig cells was investigated to outline 
the function and regulation of Leydig cells.
MATERIALS AND METHODS
Animals and testis preparation
C57/BL6 (Jackson Labs, CA, USA) male mice were housed in 
a barrier facility under normal light and dark conditions and 
fed ad libitum. Testes were isolated at postpartum days (PPD) 
1 and 5 and postpartum weeks (PPW) 3, 4, 5, and 12. Testes 
were removed, fixed in 10% formalin, and embedded in par-
affin. All procedures were approved by the Animal Care and 
Use Committees at Yonsei University College of Medicine and 
Northwestern University.
Plasmid and adenovirus construction
The mStARp-Luc plasmid was constructed by inserting the 
mouse steroidogenic acute regulatory (StAR) promoter (2730 
bps) into the multiple cloning site of pGL3 basic vector. As syn-
thetic poly A (spa) region in PGL3 basic vector contained two 
FOXO binding sequences, we removed them using NotI and 
KpnI.16 The human FOXO3 triple mutant (FOXO3-TM) was 
generated by substituting Thr32, Ser253, and Ser315 with alanine 
residues. This FOXO3-TM cannot be phosphorylated by Akt 
and is constitutively activated.17,18 Recombinant adenoviral 
vectors carrying FOXO3 [wild type (WT) or TM] were generated 
as previously described.8 Adenovirus carrying β-galactosidase 
(Ad-Gal) was used as a control.8 
 
Cell culture
MA10 and R2C cells were cultured in Dulbecco’s Modified Ea-
gle’s Medium (DMEM) supplemented with 15% horse serum 
(HS), 5% fetal bovine serum (FBS), and 100 U/mL penicillin 
and streptomycin. The cultures were maintained at 37°C in a 
humidified atmosphere of 5% CO2. R2C cells were cultured in 
DMEM with 15% FBS and 5% HS, and infected with β-gal ade-
novirus (5 pfu) or TM FOXO3 virus (1 or 5 pfu) for 24 hr. The 
cultures were then maintained in serum free media for 48 hr. 
Testosterone levels in the medium were measured by radio-
immunoassay (Diagnostic Systems Laboratories Inc., Webster, 
TX, USA), and cells were collected for a Western blot. R2C cells 
were plated and maintained in serum-free medium for 24 hr 
before treatment with 10 IU IVF-C (human chromic gonado-
tropin, LG Life Science, Seoul, Korea) or vehicle. To block the 
PI3K pathway, 20 μM of LY293002 were applied for 2 hr and 
then 10 IU of IVF-C were added.
Transfection and luciferase assay
One day before transfection, 293FT cells were transferred to 
12-well plates. The mStAR reporter and expression plasmids 
were transfected at the indicated concentration for 6 hr with 
Lipofectamine 2000 (Invitrogen, Urlington, ON, Canada). Af-
ter a set time, cell were lysed in 100 uL reporter lysis buffer 
(Promega Corp, San Luis Obispo, CA, USA) and assayed for 
luciferase activity using a lumat LB 9507 luminometer (EG&G, 
Berthold, Germany). 
Immunofluorescence
For immunohistochemistry, 4 µm sections were cut using a 
Jung microtome (Leica, Heerbrugg, Switzerland). Sections 
were deparaffinized in xylene and hydrated in graded etha-
nol, followed by antigen retrieval in sodium citrate buffer. Sec-
tions were blocked in normal serum (5%) for 60 minutes and 
incubated with primary antibody at 4°C overnight. After wash-
ing with Tris-buffered saline+0.05% Tween-20, Texas-red and 
fluorescein isothiocyanate-labeled donkey secondary anti-
bodies (1:200, Jackson Immuno Research Lab) were added, 
and sections were incubated for 2 hr at room temperature. 
The slides were washed again and mounted with Vectashield 
medium (Vector Laboratories, Burlingame, CA, USA). A Zeiss 
Axioskop (Thornwood, NY, USA) was used to visualize the 
cells. Primary antibodies included rabbit polyclonal Foxo1 
(1:500, SC-67140; Santa Cruz, CA, USA), Foxo3 (1:500, F2178; 
Sigma, MO, USA), and Foxo4 (1:200, A8975, Sigma) with goat 
anti-GATA-4 (1:200, Santa Cruz, CA, USA).
Western blot analysis
Cells were lysed in radioimmunoprecipitation assay buffer (20 
mM Tris pH 7.5, 2 mM ethylenediaminetetraacetic acid, 150 
mM NaCl, 0.5% phosphatase inhibitor, 0.5% protease inhibi-
tors). Fifty grams of protein was separated on 10% sodium do-
decyl sulfate gels, followed by semi-dry Western blotting. Sub-
sequently, membranes were blocked with 5% bovine serum 
albumin (BSA) in TBST (50 mM Tris-HCl, pH 7.5 and 150 mM 
NaCl containing 0.05% Tween 20).19 The blots were probed 
overnight with Foxo3 (1:1000, Sigma F-2178), AKT (1:1000, 
Cell Signaling 4691), pAKT (1:1000, Cell Signaling 4060), and 
phospho-Foxo3 (1:1000, Cell Signaling 2599) in 5% BSA con-
taining TBST (10 mM Tris pH 8.0, 150 mM NaCl, 0.05% Twe-
en-20). After incubating with an anti-rabbit secondary anti-
body coupled with horseradish peroxidase, the immunocom-
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plexes were visualized with enhanced chemiluminescence. 
Statistical analysis
Quantitative data are expressed as mean standard deviation. 
Student’s t-test (two-tails) was performed using SPSS 10.0 soft-
ware (SPSS Inc., Chicago, IL, USA), and all p-values<0.05 were 
considered statistically significant. Data are presented as the 
mean±standard error of the mean.
RESULTS
Foxo3 expression differed in Leydig cells according 
to age 
We investigated the expression of Foxo3 using double-immu-
nostaining with GATA4, which is expressed in Sertoli cells, 
steroidogenic Leydig cells, and other testicular somatic cells 
in the testes.20 As shown in Fig. 1, Foxo3 expression was abun-
dant in spermatogonial cytoplasm during the pre-pubertal 
period but was undetected after puberty. Foxo3 expression in 
Leydig cells, however, began to appear at 3 weeks after birth 
and became more widespread. Most Foxo3 protein was de-
tected in the nucleus at 3–4 weeks after birth. At 5 and 12 weeks, 
however, it was localized in both the nucleus and cytoplasm, 
which suggests active shuttling between these compartments. 
Foxo3 localization in Leydig cells was regulated by age and 
seemed to be related to its function.
 
hCG treatment increased Foxo3 phosphorylation in 
30 min
As Foxo3 showed active shuttling in the Leydig cells around 
puberty, we hypothesized that LH hormone could be a major 
regulator of Foxo3 function, since Leydig cells are the primary 
site of LH hormone activity. Post-translational modification is 
a major mechanism that regulates the localization of Foxo 
proteins. Among various post-translational modifications, PI3K 
dependent phosphorylation of Foxo3 at Thr32, Ser253, and Ser315 
residues is key regulator of excluding Foxo protein from the 
nucleus. We looked into the phosphorylation of Thr32 of Foxo3 
by hCG in the R2C cells since LH and hCG are nearly identical 
at the molecular level. R2C cells treated with hCG exhibited 
increased levels of phosphorylated AKT at 30 min, which de-
creased thereafter. Foxo3 phosphorylation followed a similar 
pattern. This indicates that hCG stimulates the PI3K pathway 
to regulate the phosphorylation of Foxo3. To confirm this suspi-
cion, we investigated the phosphorylation of Foxo3 after block-
ing the PI3K pathway by treatment with 20 uM of LY294002. 
Blocking the PI3K pathway decreased hCG-mediated phos-
phorylation of Foxo3 and AKT. This result confirmed that hCG/
LH influences the phosphorylation of Foxo3 via the PI3K path-
way, mediating whether Foxo3 stays in the cytoplasm or in the 
nucleus. 
 
Testosterone levels decreased following FOXO3 virus 
infection
To elucidate the role of FOXO3 in Leydig cells, FOXO3 expres-
sion was confirmed in the Leydig cell lines R2C and MA10 
(Fig. 3A). Both cell lines expressed FOXO3 protein, but levels 
thereof were higher in R2C cells. Because the main function of 
Leydig cells is to produce testosterone, hormone levels were 
measured in R2C cells over-expressing FOXO3. Adenovirus 
was used to express WT- and TM-FOXO3. TM-FOXO3 has ala-
nine residues at each of the three AKT phosphorylation sites 
and is constitutively active in the nucleus.17 Over-expression 
of WT-FOXO3 decreased testosterone levels in R2C cells, which 
decreased further following TM-FOXO3 over-expression (Fig. 
3B). This indicates that FOXO3 negatively regulates testoster-
one synthesis and is more active in the nucleus. 
StAR protein levels following FOXO3 virus infection
To determine how FOXO3 decreases testosterone levels in R2C 
cells, we investigated StAR protein levels by TM-FOXO3. In 
testosterone production, cholesterol transportation to the in-
PPD 1
PPD 5
PPW 3
PPW 4
PPW 5
PPW 12
Foxo3 (Cy3) Foxo3 & GATA4
(FITC)
Overlay
with DAPI
Fig. 1. Foxo3 is detected in Leydig cells. In C57/BL6 male mice, testes 
were isolated at postpartum days (PPD) 1 and 5 and postpartum weeks 
(PPW) 3, 4, 5, and 12. Double-immunostaining was performed using each 
rabbit polyclonal Foxo3 with goat anti-GATA4 and observed under a laser 
scanning microscope, ×400 magnification. Scale bar indicates 200 um. 
FITC, fluorescein isothiocyanate; DAPI, 4’,6-diamidino-2-phenylindole.
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ner membrane of mitochondria is a rate-limiting step. StAR is 
located in mitochondria and plays a key role in steroid hor-
mone synthesis by transporting cholesterol from the outer mi-
tochondrial membrane to the inner membrane and convert-
ing it to pregnelone.21 TM-FOXO3 expression decreased StAR 
protein levels in a dose-dependent manner (Fig. 4A). To in-
vestigate whether FOXO3 directly regulates StAR gene expres-
sion, a reporter vector system was used. A mouse StAR report-
er vector containing 2730 bps of the StAR promoter sequence 
was constructed. Cotransfecting WT FOXO3 with the reporter 
vector decreased mStAR promoter activity, and TM FOXO3 
further decreased the reported activity (Fig. 4B). This finding 
corresponds with those for StAR protein levels, reflecting that 
FOXO3 directly regulates StAR gene expression.
DISCUSSION
While the role of Foxo3 in the female reproductive system has 
been widely studied and clarified, little is known about the in-
volvement of Foxo3 in male gonad development. In this study, 
the presence and location of Foxo3 transcription factors in 
mouse Leydig cells, the regulation of its location, and its role 
in testosterone production were identified. We observed that 
Foxo3 is mainly located within the testicles from birth to PPD 
5. However, after PPW 3, Foxo3 was mainly located in Leydig 
cells, and its expression pattern depended on age. At PPW 3 
and 4, most Foxo3 was detected in the nucleus. Later, it was 
detected in cytoplasm and the nucleus, indicating that Foxo3 
localization is regulated in Leydig cells. Thus, Foxo3 location 
plays an important role in the activity of Leydig cells. The im-
portance of Foxo protein in male reproductive system is also 
relfected by the fact that Foxo1 and Foxo4 are also detected in 
the testes (data not shown). Indeed, the importance of Foxo1 
on spermatogonium has been emphasized in a previous study 
in which germ line specific Foxo1 knock out mice showed de-
fects in proliferative expansion, and thus, testes were small by 
PPD 21 due to spermatogonial arrest and failure of meiotic 
initiation.14
Nevertheless, Foxo3 was detected in both the cytoplasm 
and nucleus at 5–12 weeks after birth in Leydig cells, showing 
active shuttling between the nucleus and the cytoplasm. Th-
erefore, we hypothesized that puberty hormone may be in-
volved in regulating gonadal development. Gonadotropins FSH 
and LH were expected to regulate Foxo3 localization because 
these gonadotropins are secreted by the pituitary and act on 
the ovaries and testes to initiate sexual maturation and to main-
tain a cyclic reproductive function.22,23 Among gonadotropins, 
LH was a candidate factor for on Foxo3 localization in Leydig 
cells. In females, steroidogenesis is primarily controlled by LH 
Fig. 2. LH/hCG regulates Foxo3 localization. (A) R2C cells were cultured in the serum-starved condition for 24 hr and stimulated with 10 IU of hCG for 10, 30, 
and 60 minutes. (B) To block the PI3K pathway, 20 uM of LY294002 was pretreated for 2 hr and then 10 IU of hCG was added for 30 min. Cell lysates were 
extracted and western blots were performed. The grape data was presented as the mean (±SEM) of triplicated experiments from three independent ex-
periments and are presented as fold changes related to 0 min treatment in (A) and no-treatment in (B). Significant differences between control are denot-
ed as *p<0.05, **p<0.01, †p<0.05, and ††p<0.01 compared btween 30 min and 60 min. Similar results were obtained in three independent experiments. LH, 
luteinizing hormone; hCG, human chorionic gonadotropin; PI3K, phosphoinositide 3-kinase; SEM, standard error of the mean; NS, not significant.
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in Theca cells.22,24,25 LH stimulates Theca cells to produce tes-
tosterone and maintains progesterone production by induc-
ing the genes involved in steroidogenesis: cytochrome P450 
side-chain cleavage enzyme (CYP11A1), 3β-hydroxysteroid 
dehydrogenase, 17α-hydroxylase/C17–20 lyase cytochrome 
P450 (CYP17A1), and  StAR protein.26-30 In bovine Theca cells, 
Akt is constitutively expressed, but it is gradually phosphory-
lated through LH exposure.31 AKT signaling by LH does not 
only influence females, but also male hormone synthesis. In 
primary cultures of immature rat Leydig cells, LH/chorionic 
gonadotropin stimulated ERK1/2 and Akt phosphoryla-
tion.25,32,33 This result was replicated in our study (Fig. 2A). hCG 
treatment not only increased pAKT levels, but also pFoxo3 levels 
in 30 min. Activated Akt signaling by LH/hCG can increase 
Foxo3 phosphorylation at Thr32, Ser253, and Ser315, causing Foxo3 
to be transported from the nucleus to cytoplasm. This finding 
indicates that LH released from the pituitary regulates Foxo3 
localization. As PI3K pathway activates AKT signaling path-
way, we blocked the PI3K pathway to confirm whether hCG 
stimulates induction of the phosphorylation of Foxo3 via the 
PI3K pathway. Pre-treatment of LY294002 (PI3K pathway inhib-
itor) reduced hCG-mediated pAKT and pFoxo3 levels, indicat-
ing the PI3K pathway regulates the localization of Foxo3 (Fig. 2B). 
To determine the function of Foxo3 in Leydig cells, we mea-
sured testosterone levels in a Leydig cell line of R2C cells, as 
the main function of Leydig cells is testosterone synthesis. Our 
study revealed that FOXO3 down-regulates testosterone levels 
in Leydig cells (Fig. 3B). Testosterone synthesis consists of a 
series of steroid precursor and enzyme syntheses. The rate-
limiting step in steroid synthesis is catalyzed by StAR protein, 
which transports cholesterol from the outer mitochondrial 
membrane to the inner membrane.34,35 StAR protein levels de-
creased dramatically in a dose-dependent manner in R2C cells 
infected with TM-FOXO3 (Fig. 4A). Next, we observed whether 
mStAR promoter activity is directly down-regulated by FOXO3. 
FOXO3 down-regulated mStAR promoter activity, which was 
more significant with TM-FOXO3 expression (Fig. 4B). This re-
sult correlates with the reduced testosterone levels caused by 
over-expression of WT and TM-FOXO3 in R2C cells (Fig. 3B). 
From those results, we concluded that Foxo3 plays an impor-
tant role in testosterone hormone synthesis. However, there is 
no reported phenotype in Foxo3 KO male mice. It seems to be 
Fig. 3. FOXO3 over-expression decreases testosterone levels in Leydig 
cell lines. (A) We confirmed the Foxo3 levels in MA10 and R2C cells. To 
elucidate the role of Foxo3 in the nucleus, we constructed a constitutively 
active form of human FOXO3 by replacing the three AKT phosphorylation 
sites (T32, S253, and S315) with alanine. (B) Testosterone levels were mea-
sured in R2C cells infected with Ad-LacZ (empty), WT-FOXO3, or TM- 
FOXO3 adenovirus (5 pfu/cell for 48 hr). Testosterone levels decreased by 
WT-FOXO3 infection and more significantly by TM-FOXO3. *p<0.05, 
**p<0.01 vs. empty or WT-FOXO3 infection sample. Similar results were ob-
tained in three independent experiments. WT, wild type; TM, triple mutant.
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that Leydig cells not only express Foxo3 but also Foxo4 (data 
not shown). Foxo4 seems to have similar function in Leydig 
cells. 
Foxo3 may be regulated by other signaling pathways, such 
as insulin like growth factor (IGF)-1 signaling. In the testes, 
IGF-1 reaches its maximum expression at PPW 4 when puber-
tal testosterone rises.36 Growth factor have been shown to ac-
tiviate AKT, which leads to the phosphorylation of Foxo3 at its 
14-3-3 binding site and determines Foxo3 relocalization to the 
cytoplasm.9 This result with our observations led us to hypoth-
esize that during the first four weeks, IGF-1 phosphorylates 
Foxo3, trapping it in the cytoplasm through interactions with 
14-3-3. Once IGF-1 has reached its peak expression and de-
creases, LH signaling-mediating Foxo3 may become involved 
in the regulation of gonadal development by regulating tes-
tosterone hormone. 
In summary, this study investigated Foxo3 localization and 
its role in the testes. Foxo3 is expressed in the testes, but its ex-
pression sites differ according to age. Foxo3 expression in Ley-
dig cells appears in the nucleus before puberty, and it shows 
active shuttling in between the nucleus and the cytoplasm af-
ter puberty. We confirmed the role of Foxo3 in Leydig cells as a 
negative regulator for testosterone hormone by reducing StAR 
gene expression. The fact that phosphorylated Foxo3 by hCG/
LH suggests a possible mechanism that LH stimulates testos-
terone levels via PI3K-dependent inhibition of Foxo3 action in 
Leydig cells.
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